Join
Live feed
·
INSIDERFilingvia Quantisnow
Cyclacel Pharmaceuticals Inc. logo

SEC Form 4: Barker Sam L sold $43 worth of shares (12 units at $3.57), decreasing direct ownership by 0.35% to 3,374 units

ByQuantisnow·Wall Street's wire, on your screen.
CYCC· Cyclacel Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYCC (Cyclacel Pharmaceuticals Inc.) and more on Quantisnow.